Skip to main content

Table 1 Patient characteristics according to the presence of a cardiac catheterisation laboratory

From: 30-day in-hospital mortality after acute myocardial infarction in Tuscany (Italy): An observational study using hospital discharge data

Characteristics

All (n=5,832)

Presence of cardiac catheterisation lab.

No (n=2,315)

Yes (n=3,517)

p-value

Age in years, mean [SD]

72.38 [13.05]

74.62 [12.39]

70.90 [13.26]

<0.001

Gender (%)

   

<0.001

Male

3,610 (61.90)

1,335 (57.67)

2,275 (64.69)

 

Female

2,222 (38.10)

980 (42.33)

1,242 (35.31)

 

Hospital stay in days, mean [SD]

6.79 [5.62]

6.43 [5.54]

7.03 [5.67]

<0.001

Comorbidities (%)

   

<0.001

No

3,918 (67.18)

1,412 (60.99)

2,506 (71.25)

 

Yes

1,914 (32.82)

903 (39.01)

1,011 (28.75)

 

Specific comorbidities (%)

    

Hematologic diseases

181 (3.10)

81 (3.50)

100 (2.84)

0.158

History of heart failure

352 (6.04)

184 (7.95)

168 (4.78)

<0.001

Cerebrovascular diseases

273 (4.68)

139 (6.00)

134 (3.81)

<0.001

History of cerebrovascular diseases

261 (4.48)

123 (5.31)

138 (3.92)

0.012

Vascular diseases

259 (4.44)

107 (4.62)

152 (4.32)

0.588

History of vascular diseases

177 (3.03)

77 (3.33)

100 (2.84)

0.293

Chronic nephropathies

470 (8.06)

234 (10.11)

236 (6.71)

<0.001

History of chronic nephropathies

237 (4.06)

128 (5.53)

109 (3.10)

<0.001

History of tumours

167 (2.86)

81 (3.50)

86 (2.45)

0.018

History of diabetes

373 (6.40)

185 (7.99)

188 (5.35)

<0.001

History of hypertensive disease

582 (9.98)

278 (12.01)

304 (8.64)

<0.001

History of other forms of ischemic heart disease

597 (10.24)

294 (12.70)

303 (8.62)

<0.001

History of conduction disorders and cardiac dysrhythmias

288 (4.94)

152 (6.57)

136 (3.87)

<0.001

History of COPD

182 (3.10)

105 (4.54)

77 (2.19)

<0.001

ST-segment elevation (%)

   

<0.001

NSTEMI

3,082 (52.85)

1,509 (65.18)

1,573 (44.73)

 

STEMI

2,750 (47.15)

806 (34.82)

1,944 (55.27)

 
  1. COPD Chronic obstructive pulmonary disease, SD standard deviation, STEMI ST elevation myocardial infarction, NSTEMI Non-ST elevation myocardial infarction.